{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T03:53:08Z","timestamp":1792813988968,"version":"4.5.0"},"reference-count":95,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,11,21]],"date-time":"2017-11-21T00:00:00Z","timestamp":1511222400000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci. China Life Sci."],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1007\/s11427-017-9197-5","type":"journal-article","created":{"date-parts":[[2017,11,23]],"date-time":"2017-11-23T12:31:26Z","timestamp":1511440286000},"page":"14-23","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":88,"title":["AMPK and cardiac remodelling"],"prefix":"10.1007","volume":"61","author":[{"given":"Yenan","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,11,21]]},"reference":[{"key":"9197_CR1","doi-asserted-by":"publisher","first-page":"1442","DOI":"10.1016\/j.bbalip.2016.03.015","volume":"1861","author":"N.A. Abumrad","year":"2016","unstructured":"Abumrad, N.A., and Goldberg, I.J. (2016). CD36 actions in the heart: lipids, calcium, inflammation, repair and more? Biochim Biophys Acta 1861, 1442\u20131449.","journal-title":"Biochim Biophys Acta"},{"key":"9197_CR2","first-page":"12509","volume":"8","author":"F. Ai","year":"2015","unstructured":"Ai, F., Chen, M., Yu, B., Yang, Y., Xu, G., Gui, F., Liu, Z., Bai, X., and Chen, Z. (2015). Berberine regulates proliferation, collagen synthesis and cytokine secretion of cardiac fibroblasts via AMPK-mTOR-p70s6k signaling pathway. Int J Clin Exp Pathol 8, 12509\u201312516.","journal-title":"Int J Clin Exp Pathol"},{"key":"9197_CR3","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1159\/000369706","volume":"35","author":"I. Alesutan","year":"2015","unstructured":"Alesutan, I., Voelkl, J., St\u00f6ckigt, F., Mia, S., Feger, M., Primessnig, U., Sopjani, M., Munoz, C., Borst, O., Gawaz, M., Pieske, B., Metzler, B., Heinzel, F., Schrickel, J.W., and Lang, F. (2015). AMP-activated protein kinase A1 regulates cardiac gap junction protein connexin 43 and electrical remodeling following pressure overload. Cell Physiol Biochem 35, 406\u2013418.","journal-title":"Cell Physiol Biochem"},{"key":"9197_CR4","doi-asserted-by":"publisher","first-page":"e72120","DOI":"10.1371\/journal.pone.0072120","volume":"8","author":"J. Bai","year":"2013","unstructured":"Bai, J., Zhang, N., Hua, Y., Wang, B., Ling, L., Ferro, A., and Xu, B. (2013). Metformin inhibits angiotensin II-induced differentiation of cardiac fibroblasts into myofibroblasts. PLoS ONE 8, e72120.","journal-title":"PLoS ONE"},{"key":"9197_CR5","doi-asserted-by":"publisher","first-page":"C1554","DOI":"10.1152\/ajpcell.00010.2009","volume":"297","author":"B. Benziane","year":"2009","unstructured":"Benziane, B., Bj\u00f6rnholm, M., Lantier, L., Viollet, B., Zierath, J.R., and Chibalin, A.V. (2009). AMP-activated protein kinase activator A-769662 is an inhibitor of the Na+-K+-ATPase. Am J Physiol Cell Physiol 297, C1554\u2013C1566.","journal-title":"Am J Physiol Cell Physiol"},{"key":"9197_CR6","doi-asserted-by":"publisher","first-page":"613","DOI":"10.1038\/nm1582","volume":"13","author":"A. Car\u00e8","year":"2007","unstructured":"Car\u00e8, A., Catalucci, D., Felicetti, F., Bonci, D., Addario, A., Gallo, P., Bang, M.L., Segnalini, P., Gu, Y., Dalton, N.D., Elia, L., Latronico, M.V., H\u00f8ydal, M., Autore, C., Russo, M.A., Dorn, G.W.Nd., Ellingsen, O., Ruiz-Lozano, P., Peterson, K.L., Croce, C.M., Peschle, C., and Condorelli, G. (2007). MicroRNA-133 controls cardiac hypertrophy. Nat Med 13, 613\u2013618.","journal-title":"Nat Med"},{"key":"9197_CR7","doi-asserted-by":"publisher","first-page":"24194","DOI":"10.1074\/jbc.M802869200","volume":"283","author":"A.Y.M. Chan","year":"2008","unstructured":"Chan, A.Y.M., Dolinsky, V.W., Soltys, C.L.M., Viollet, B., Baksh, S., Light, P.E., and Dyck, J.R.B. (2008). Resveratrol inhibits cardiac hypertrophy via AMP-activated protein kinase and Akt. J Biol Chem 283, 24194\u201324201.","journal-title":"J Biol Chem"},{"key":"9197_CR8","doi-asserted-by":"publisher","first-page":"32771","DOI":"10.1074\/jbc.M403528200","volume":"279","author":"A.Y.M. Chan","year":"2004","unstructured":"Chan, A.Y.M., Soltys, C.L.M., Young, M.E., Proud, C.G., and Dyck, J.R.B. (2004). Activation of AMP-activated protein kinase inhibits protein synthesis associated with hypertrophy in the cardiac myocyte. J Biol Chem 279, 32771\u201332779.","journal-title":"J Biol Chem"},{"key":"9197_CR9","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.ejphar.2015.10.043","volume":"769","author":"W. Chang","year":"2015","unstructured":"Chang, W., Zhang, M., Meng, Z., Yu, Y., Yao, F., Hatch, G.M., and Chen, L. (2015). Berberine treatment prevents cardiac dysfunction and remodeling through activation of 5\u2032-adenosine monophosphate-activated protein kinase in type 2 diabetic rats and in palmitate-induced hypertrophic H9c2 cells. Eur J Pharmacol 769, 55\u201363.","journal-title":"Eur J Pharmacol"},{"key":"9197_CR10","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1038\/aps.2010.73","volume":"31","author":"B. Chen","year":"2010","unstructured":"Chen, B., Ma, Y., Meng, R., Xiong, Z., Wang, H., Zeng, J., Liu, C., and Dong, Y. (2010a). Activation of AMPK inhibits cardiomyocyte hypertrophy by modulating of the FOXO1\/MuRF1 signaling pathway in vitro. Acta Pharmacol Sin 31, 798\u2013804.","journal-title":"Acta Pharmacol Sin"},{"key":"9197_CR11","doi-asserted-by":"publisher","first-page":"e41574","DOI":"10.1371\/journal.pone.0041574","volume":"7","author":"H. Chen","year":"2012","unstructured":"Chen, H., Untiveros, G.M., McKee, L.A.K., Perez, J., Li, J., Antin, P.B., and Konhilas, J.P. (2012). Micro-RNA-195 and-451 regulate the LKB1\/AMPK signaling axis by targeting MO25. PLoS ONE 7, e41574.","journal-title":"PLoS ONE"},{"key":"9197_CR12","doi-asserted-by":"publisher","first-page":"3067","DOI":"10.1007\/s11033-009-9879-6","volume":"37","author":"L.L. Chen","year":"2010","unstructured":"Chen, L.L., Zhu, T.B., Yin, H., Huang, J., Wang, L.S., Cao, K.J., and Yang, Z.J. (2010b). Inhibition of MAPK signaling by eNOS gene transfer improves ventricular remodeling after myocardial infarction through reduction of inflammation. Mol Biol Rep 37, 3067\u20133072.","journal-title":"Mol Biol Rep"},{"key":"9197_CR13","volume-title":"Br J Pharmacol","author":"R. Chen","year":"2017","unstructured":"Chen, R., Feng, Y., Wu, J., Song, Y., Li, H., Shen, Q., Li, D., Zhang, J., Lu, Z., Xiao, H., and Zhang, Y. (2017). Metformin attenuates angiotensin II-induced TGF\u03b21 expression by targeting hepatocyte nuclear factor-4-\u03b1. Br J Pharmacol in press doi: 10.1111\/bph.13753."},{"key":"9197_CR14","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1161\/CIRCRESAHA.108.187567","volume":"104","author":"Z. Chen","year":"2009","unstructured":"Chen, Z., Peng, I.C., Sun, W., Su, M.I., Hsu, P.H., Fu, Y., Zhu, Y., DeFea, K., Pan, S., Tsai, M.D., and Shyy, J.Y.J. (2009). AMP-activated protein kinase functionally phosphorylates endothelial nitric oxide synthase Ser633. Circ Res 104, 496\u2013505.","journal-title":"Circ Res"},{"key":"9197_CR15","doi-asserted-by":"publisher","first-page":"21837","DOI":"10.1074\/jbc.M110.120709","volume":"285","author":"P. Chinnakkannu","year":"2010","unstructured":"Chinnakkannu, P., Samanna, V., Cheng, G., Ablonczy, Z., Baicu, C.F., Bethard, J.R., Menick, D.R., Kuppuswamy, D., and Cooper Iv, G. (2010). Site-specific microtubule-associated protein 4 dephosphorylation causes microtubule network densification in pressure overload cardiac hypertrophy. J Biol Chem 285, 21837\u201321848.","journal-title":"J Biol Chem"},{"key":"9197_CR16","doi-asserted-by":"publisher","first-page":"20186","DOI":"10.1074\/jbc.M803020200","volume":"283","author":"H.C. Choi","year":"2008","unstructured":"Choi, H.C., Song, P., Xie, Z., Wu, Y., Xu, J., Zhang, M., Dong, Y., Wang, S., Lau, K., and Zou, M.H. (2008). Reactive nitrogen species is required for the activation of the AMP-activated protein kinase by statin in vivo. J Biol Chem 283, 20186\u201320197.","journal-title":"J Biol Chem"},{"key":"9197_CR17","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s11745-017-4246-1","volume":"52","author":"S.Y. Choi","year":"2017","unstructured":"Choi, S.Y., Park, J.S., Roh, M.S., Kim, C.R., Kim, M.H., and Serebruany, V. (2017). Inhibition of angiotensin II-induced cardiac fibrosis by atorvastatin in adiponectin knockout mice. Lipids 52, 415\u2013422.","journal-title":"Lipids"},{"key":"9197_CR18","doi-asserted-by":"publisher","first-page":"89","DOI":"10.2217\/fca.11.76","volume":"8","author":"Z.Z. Chong","year":"2012","unstructured":"Chong, Z.Z., Wang, S., Shang, Y.C., and Maiese, K. (2012). Targeting cardiovascular disease with novel SIRT1 pathways. Future Cardiol 8, 89\u2013100.","journal-title":"Future Cardiol"},{"key":"9197_CR19","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yjmcc.2013.07.005","volume":"63","author":"K.A. Cieslik","year":"2013","unstructured":"Cieslik, K.A., Taffet, G.E., Crawford, J.R., Trial, J.A., Mejia Osuna, P., and Entman, M.L. (2013). AICAR-dependent AMPK activation improves scar formation in the aged heart in a murine model of reperfused myocardial infarction. J Mol Cell Cardiol 63, 26\u201336.","journal-title":"J Mol Cell Cardiol"},{"key":"9197_CR20","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.yjmcc.2016.01.001","volume":"91","author":"E.P. Daskalopoulos","year":"2016","unstructured":"Daskalopoulos, E.P., Dufeys, C., Bertrand, L., Beauloye, C., and Horman, S. (2016). AMPK in cardiac fibrosis and repair: actions beyond metabolic regulation. J Mol Cell Cardiol 91, 188\u2013200.","journal-title":"J Mol Cell Cardiol"},{"key":"9197_CR21","doi-asserted-by":"publisher","first-page":"866","DOI":"10.1161\/01.HYP.0000037969.41360.CC","volume":"40","author":"Q.N. Diep","year":"2002","unstructured":"Diep, Q.N., Amiri, F., Touyz, R.M., Cohn, J.S., Endemann, D., Neves, M.F., and Schiffrin, E.L. (2002). PPARalpha activator effects on Ang II-induced vascular oxidative stress and inflammation. Hypertension 40, 866\u2013871.","journal-title":"Hypertension"},{"key":"9197_CR22","doi-asserted-by":"publisher","first-page":"H2557","DOI":"10.1152\/ajpheart.00329.2006","volume":"291","author":"V.W. Dolinsky","year":"2006","unstructured":"Dolinsky, V.W., and Dyck, J.R.B. (2006). Role of AMP-activated protein kinase in healthy and diseased hearts. Am J Physiol Heart Circ Physiol 291, H2557\u2013H2569.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9197_CR23","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1016\/j.bbrc.2008.01.099","volume":"368","author":"J. Du","year":"2008","unstructured":"Du, J., Guan, T., Zhang, H., Xia, Y., Liu, F., and Zhang, Y. (2008). Inhibitory crosstalk between ERK and AMPK in the growth and proliferation of cardiac fibroblasts. Biochem Biophys Res Commun 368, 402\u2013407.","journal-title":"Biochem Biophys Res Commun"},{"key":"9197_CR24","doi-asserted-by":"publisher","first-page":"H749","DOI":"10.1152\/ajpheart.00935.2011","volume":"304","author":"J.T. Fassett","year":"2013","unstructured":"Fassett, J.T., Hu, X., Xu, X., Lu, Z., Zhang, P., Chen, Y., and Bache, R.J. (2013). AMPK attenuates microtubule proliferation in cardiac hypertrophy. Am J Physiol Heart Circ Physiol 304, H749\u2013H758.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"9197_CR25","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1161\/CIRCULATIONAHA.105.591446","volume":"113","author":"J.A.M. Foody","year":"2006","unstructured":"Foody, J.A.M., Shah, R., Galusha, D., Masoudi, F.A., Havranek, E.P., and Krumholz, H.M. (2006). Statins and mortality among elderly patients hospitalized with heart failure. Circulation 113, 1086\u20131092.","journal-title":"Circulation"},{"key":"9197_CR26","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/aps.2010.229","volume":"32","author":"Y. Fu","year":"2011","unstructured":"Fu, Y., Xiao, H., Ma, X., Jiang, S., Xu, M., and Zhang, Y. (2011). Metformin attenuates pressure overload-induced cardiac hypertrophy via AMPK activation. Acta Pharmacol Sin 32, 879\u2013887.","journal-title":"Acta Pharmacol Sin"},{"key":"9197_CR27","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1161\/ATVBAHA.107.156687","volume":"28","author":"K. Fujita","year":"2008","unstructured":"Fujita, K., Maeda, N., Sonoda, M., Ohashi, K., Hibuse, T., Nishizawa, H., Nishida, M., Hiuge, A., Kurata, A., Kihara, S., Shimomura, I., and Funahashi, T. (2008). Adiponectin protects against angiotensin II-induced cardiac fibrosis through activation of PPAR-alpha. Arterioscler Thromb Vasc Biol 28, 863\u2013870.","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"9197_CR28","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1038\/nrcardio.2011.154","volume":"8","author":"O. Gjesdal","year":"2011","unstructured":"Gjesdal, O., Bluemke, D.A., and Lima, J.A. (2011). Cardiac remodeling at the population level\u2014risk factors, screening, and outcomes. Nat Rev Cardiol 8, 673\u2013685.","journal-title":"Nat Rev Cardiol"},{"key":"9197_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.apsb.2015.06.002","volume":"6","author":"D. Grahame Hardie","year":"2016","unstructured":"Grahame Hardie, D. (2016). Regulation of AMP-activated protein kinase by natural and synthetic activators. Acta Pharm Sin B 6, 1\u201319.","journal-title":"Acta Pharm Sin B"},{"key":"9197_CR30","doi-asserted-by":"publisher","first-page":"103","DOI":"10.1093\/cvr\/cvp384","volume":"86","author":"N. Gurusamy","year":"2010","unstructured":"Gurusamy, N., Lekli, I., Mukherjee, S., Ray, D., Ahsan, M.K., Gherghiceanu, M., Popescu, L.M., and Das, D.K. (2010). Cardioprotection by resveratrol: a novel mechanism via autophagy involving the mTORC2 pathway. Cardiovasc Res 86, 103\u2013112.","journal-title":"Cardiovasc Res"},{"key":"9197_CR31","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.molcel.2008.03.003","volume":"30","author":"D.M. Gwinn","year":"2008","unstructured":"Gwinn, D.M., Shackelford, D.B., Egan, D.F., Mihaylova, M.M., Mery, A., Vasquez, D.S., Turk, B.E., and Shaw, R.J. (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell 30, 214\u2013226.","journal-title":"Mol Cell"},{"key":"9197_CR32","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1016\/j.bbrc.2007.01.141","volume":"355","author":"D.D.J. Habets","year":"2007","unstructured":"Habets, D.D.J., Coumans, W.A., Voshol, P.J., den Boer, M.A.M., Febbraio, M., Bonen, A., Glatz, J.F.C., and Luiken, J.J.F.P. (2007). AMPK-mediated increase in myocardial long-chain fatty acid uptake critically depends on sarcolemmal CD36. Biochem Biophys Res Commun 355, 204\u2013210.","journal-title":"Biochem Biophys Res Commun"},{"key":"9197_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","volume":"360","author":"Heart Protection Study Collaborative Group.","year":"2002","unstructured":"Heart Protection Study Collaborative Group. (2002). MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20, 536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360, 7\u201322.","journal-title":"Lancet"},{"key":"9197_CR34","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1093\/cvr\/cvt070","volume":"99","author":"N. Hermida","year":"2013","unstructured":"Hermida, N., Markl, A., Hamelet, J., Van Assche, T., Vanderper, A., Herijgers, P., van Bilsen, M., Hilfiker-Kleiner, D., Noppe, G., Beauloye, C., Horman, S., and Balligand, J.L. (2013). HMGCoA reductase inhibition reverses myocardial fibrosis and diastolic dysfunction through AMP-activated protein kinase activation in a mouse model of metabolic syndrome. Cardiovasc Res 99, 44\u201354.","journal-title":"Cardiovasc Res"},{"key":"9197_CR35","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1111\/jcmm.12220","volume":"18","author":"J.S. Hern\u00e1ndez","year":"2014","unstructured":"Hern\u00e1ndez, J.S., Barreto-Torres, G., Kuznetsov, A.V., Khuchua, Z., and Javadov, S. (2014). Crosstalk between AMPK activation and angiotensin II-induced hypertrophy in cardiomyocytes: The role of mitochondria. J Cell Mol Med 18, 709\u2013720.","journal-title":"J Cell Mol Med"},{"key":"9197_CR36","doi-asserted-by":"publisher","first-page":"719","DOI":"10.3389\/fimmu.2017.00719","volume":"8","author":"P.B. Katare","year":"2017","unstructured":"Katare, P.B., Bagul, P.K., Dinda, A.K., and Banerjee, S.K. (2017). Toll-like receptor 4 inhibition improves oxidative stress and mitochondrial health in isoproterenol-induced cardiac hypertrophy in rats. Front Immunol 8, 719.","journal-title":"Front Immunol"},{"key":"9197_CR37","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/hr.2009.77","volume":"32","author":"Y. Izumi","year":"2009","unstructured":"Izumi, Y., Shiota, M., Kusakabe, H., Hikita, Y., Nakao, T., Nakamura, Y., Muro, T., Miura, K., Yoshiyama, M., and Iwao, H. (2009). Pravastatin accelerates ischemia-induced angiogenesis through AMP-activated protein kinase. Hypertens Res 32, 675\u2013679.","journal-title":"Hypertens Res"},{"key":"9197_CR38","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.tem.2014.11.001","volume":"26","author":"T.T. Kim","year":"2015","unstructured":"Kim, T.T., and Dyck, J.R.B. (2015). Is AMPK the savior of the failing heart? Trends Endocrinol Metab 26, 40\u201348.","journal-title":"Trends Endocrinol Metab"},{"key":"9197_CR39","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1016\/j.bbalip.2016.03.018","volume":"1861","author":"T.T. Kim","year":"2016","unstructured":"Kim, T.T., and Dyck, J.R.B. (2016). The role of CD36 in the regulation of myocardial lipid metabolism. Biochim Biophys Acta 1861, 1450\u20131460.","journal-title":"Biochim Biophys Acta"},{"key":"9197_CR40","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tem.2013.11.004","volume":"25","author":"D.A. Kubli","year":"2014","unstructured":"Kubli, D.A., and Gustafsson, A.B. (2014). Cardiomyocyte health: adapting to metabolic changes through autophagy. Trends Endocrinol Metab 25, 156\u2013164.","journal-title":"Trends Endocrinol Metab"},{"key":"9197_CR41","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1161\/CIRCRESAHA.116.304707","volume":"116","author":"Y. Kuwabara","year":"2015","unstructured":"Kuwabara, Y., Horie, T., Baba, O., Watanabe, S., Nishiga, M., Usami, S., Izuhara, M., Nakao, T., Nishino, T., Otsu, K., Kita, T., Kimura, T., and Ono, K. (2015). MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1\/AMPK pathway. Circ Res 116, 279\u2013288.","journal-title":"Circ Res"},{"key":"9197_CR42","doi-asserted-by":"publisher","first-page":"27628","DOI":"10.1074\/jbc.M805711200","volume":"283","author":"F. Lan","year":"2008","unstructured":"Lan, F., Cacicedo, J.M., Ruderman, N., and Ido, Y. (2008). SIRT1 modulation of the acetylation status, cytosolic localization, and activity of LKB1. Possible role in AMP-activated protein kinase activation. J Biol Chem 283, 27628\u201327635.","journal-title":"J Biol Chem"},{"key":"9197_CR43","doi-asserted-by":"publisher","first-page":"751","DOI":"10.3390\/nu9070751","volume":"9","author":"F. Lan","year":"2017","unstructured":"Lan, F., Weikel, K.A., Cacicedo, J.M., and Ido, Y. (2017). Resveratrol-induced AMP-activated protein kinase activation is cell-type dependent: lessons from basic research for clinical application. Nutrients 9, 751.","journal-title":"Nutrients"},{"key":"9197_CR44","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","volume":"370","author":"S. Lewington","year":"2007","unstructured":"Lewington, S., Whitlock, G., Clarke, R., Sherliker, P., Emberson, J., Halsey, J., Qizilbash, N., Peto, R., and Collins, R. (2007). Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55, 000 vascular deaths. Lancet 370, 1829\u20131839.","journal-title":"Lancet"},{"key":"9197_CR45","doi-asserted-by":"publisher","first-page":"e834","DOI":"10.1152\/ajpendo.00234.2004","volume":"287","author":"J. Li","year":"2004","unstructured":"Li, J., Hu, X., Selvakumar, P., Russell, R.R., Cushman, S.W., Holman, G.D., and Young, L.H. (2004). Role of the nitric oxide pathway in AMPKmediated glucose uptake and GLUT4 translocation in heart muscle. Am J Physiol Endocrinol Metab 287, e834\u2013E841.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9197_CR46","doi-asserted-by":"publisher","first-page":"e0148482","DOI":"10.1371\/journal.pone.0148482","volume":"11","author":"Y. Li","year":"2016","unstructured":"Li, Y., Cai, X., Guan, Y., Wang, L., Wang, S., Li, Y., Fu, Y., Gao, X., and Su, G. (2016). Adiponectin upregulates MiR-133a in cardiac hypertrophy through AMPK activation and reduced ERK1\/2 phosphorylation. PLoS ONE 11, e0148482.","journal-title":"PLoS ONE"},{"key":"9197_CR47","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1016\/j.abb.2014.06.023","volume":"558","author":"Y. Li","year":"2014","unstructured":"Li, Y., Chen, C., Yao, F., Su, Q., Liu, D., Xue, R., Dai, G., Fang, R., Zeng, J., Chen, Y., Huang, H., Ma, Y., Li, W., Zhang, L., Liu, C., and Dong, Y. (2014). AMPK inhibits cardiac hypertrophy by promoting autophagy via mTORC1. Arch Biochem Biophys 558, 79\u201386.","journal-title":"Arch Biochem Biophys"},{"key":"9197_CR48","doi-asserted-by":"publisher","first-page":"672","DOI":"10.7150\/ijbs.11883","volume":"11","author":"Z. Li","year":"2015","unstructured":"Li, Z., Wang, J., and Yang, X. (2015). Functions of autophagy in pathological cardiac hypertrophy. Int J Biol Sci 11, 672\u2013678.","journal-title":"Int J Biol Sci"},{"key":"9197_CR49","doi-asserted-by":"publisher","first-page":"111","DOI":"10.3892\/mmr.2016.5279","volume":"14","author":"L. Liu","year":"2016","unstructured":"Liu, L., Wang, C., Lin, Y., Xi, Y., Li, H., Shi, S., Li, H., Zhang, W., Zhao, Y., Tian, Y., Xu, C., and Wang, L. (2016). Suppression of calcium-sensing receptor ameliorates cardiac hypertrophy through inhibition of autophagy. Mol Med Rep 14, 111\u2013120.","journal-title":"Mol Med Rep"},{"key":"9197_CR50","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1159\/000430322","volume":"36","author":"L. Liu","year":"2015","unstructured":"Liu, L., Wang, C., Sun, D., Jiang, S., Li, H., Zhang, W., Zhao, Y., Xi, Y., Shi, S., Lu, F., Tian, Y., Xu, C., and Wang, L. (2015). Calhex231 ameliorates cardiac hypertrophy by inhibiting cellular autophagy in vivo and in vitro. Cell Physiol Biochem 36, 1597\u20131612.","journal-title":"Cell Physiol Biochem"},{"key":"9197_CR51","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1159\/000354382","volume":"60","author":"D.B. Lombard","year":"2014","unstructured":"Lombard, D.B., and Zwaans, B.M. (2014). SIRT3: as simple as it seems? Gerontology 60, 56\u201364.","journal-title":"Gerontology"},{"key":"9197_CR52","doi-asserted-by":"publisher","first-page":"1676","DOI":"10.1097\/HJH.0000000000000597","volume":"33","author":"W.W. Lu","year":"2015","unstructured":"Lu, W.W., Zhao, L., Zhang, J.S., Hou, Y.L., Yu, Y.R., Jia, M.Z., Tang, C.S., and Qi, Y.F. (2015). Intermedin1-53 protects against cardiac hypertrophy by inhibiting endoplasmic reticulum stress via activating AMP-activated protein kinase. J Hypertens 33, 1676\u20131687.","journal-title":"J Hypertens"},{"key":"9197_CR53","doi-asserted-by":"publisher","first-page":"e0129971","DOI":"10.1371\/journal.pone.0129971","volume":"10","author":"X. Ma","year":"2015","unstructured":"Ma, X., Fu, Y., Xiao, H., Song, Y., Chen, R., Shen, J., An, X., Shen, Q., Li, Z., and Zhang, Y. (2015). Cardiac fibrosis alleviated by exercise training is AMPK-dependent. PLoS ONE 10, e0129971.","journal-title":"PLoS ONE"},{"key":"9197_CR54","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.abb.2011.04.010","volume":"511","author":"R. Meng","year":"2011","unstructured":"Meng, R., Pei, Z., Zhang, A., Zhou, Y., Cai, X., Chen, B., Liu, G., Mai, W., Wei, J., and Dong, Y. (2011). AMPK activation enhances PPAR\u03b1 activity to inhibit cardiac hypertrophy via ERK1\/2 MAPK signaling pathway. Arch Biochem Biophys 511, 1\u20137.","journal-title":"Arch Biochem Biophys"},{"key":"9197_CR55","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1016\/j.ejphar.2009.08.024","volume":"620","author":"R.S. Meng","year":"2009","unstructured":"Meng, R.S., Pei, Z.H., Yin, R., Zhang, C.X., Chen, B.L., Zhang, Y., Liu, D., Xu, A.L., and Dong, Y.G. (2009). Adenosine monophosphate-activated protein kinase inhibits cardiac hypertrophy through reactivating peroxisome proliferator-activated receptor-\u03b1 signaling pathway. Eur J Pharmacol 620, 63\u201370.","journal-title":"Eur J Pharmacol"},{"key":"9197_CR56","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/1755-5922.12101","volume":"33","author":"M. Mohan","year":"2015","unstructured":"Mohan, M., McSwiggan, S., Baig, F., Rutherford, L., and Lang, C.C. (2015). Metformin and its effects on myocardial dimension and left ventricular hypertrophy in normotensive patients with coronary heart disease (the MET-REMODEL study): rationale and design of the MET-REMODEL study. Cardiovasc Ther 33, 1\u20138.","journal-title":"Cardiovasc Ther"},{"key":"9197_CR57","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.numecd.2017.04.009","volume":"27","author":"L. Nesti","year":"2017","unstructured":"Nesti, L., and Natali, A. (2017). Metformin effects on the heart and the cardiovascular system: a review of experimental and clinical data. Nutr Metab Cardiovasc Dis 27, 657\u2013669.","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"9197_CR58","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.yjmcc.2014.04.018","volume":"74","author":"G. Noppe","year":"2014","unstructured":"Noppe, G., Dufeys, C., Buchlin, P., Marquet, N., Castanares-Zapatero, D., Balteau, M., Hermida, N., Bouzin, C., Esfahani, H., Viollet, B., Bertrand, L., Balligand, J.L., Vanoverschelde, J.L., Beauloye, C., and Horman, S. (2014). Reduced scar maturation and contractility lead to exaggerated left ventricular dilation after myocardial infarction in mice lacking AMPK\u03b11. J Mol Cell Cardiol 74, 32\u201343.","journal-title":"J Mol Cell Cardiol"},{"key":"9197_CR59","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/cvr\/cvp272","volume":"84","author":"W. Peng","year":"2009","unstructured":"Peng, W., Zhang, Y., Zhu, W., Cao, C.M., and Xiao, R.P. (2009). AMPK and TNF-alpha at the crossroad of cell survival and death in ischaemic heart. Cardiovasc Res 84, 1\u20133.","journal-title":"Cardiovasc Res"},{"key":"9197_CR60","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/j.tem.2015.05.010","volume":"26","author":"D. Qi","year":"2015","unstructured":"Qi, D., and Young, L.H. (2015). AMPK: energy sensor and survival mechanism in the ischemic heart. Trends Endocrinol Metab 26, 422\u2013429.","journal-title":"Trends Endocrinol Metab"},{"key":"9197_CR61","doi-asserted-by":"publisher","first-page":"e0166845","DOI":"10.1371\/journal.pone.0166845","volume":"11","author":"K. Reichert","year":"2016","unstructured":"Reichert, K., Pereira do Carmo, H.R., Galluce Torina, A., Di\u00f3genes de Carvalho, D., Sposito, A.C., de Souza Vilarinho, K.A., da Mota Silveira-Filho, L., de Oliveira, P.P.M., and Petrucci, O. (2016). Atorvastatin improves ventricular remodeling after myocardial infarction by interfering with collagen metabolism. PLoS ONE 11, e0166845.","journal-title":"PLoS ONE"},{"key":"9197_CR62","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","volume":"365","author":"K. Richter","year":"2016","unstructured":"Richter, K., and Kietzmann, T. (2016). Reactive oxygen species and fibrosis: further evidence of a significant liaison. Cell Tissue Res 365, 591\u2013605.","journal-title":"Cell Tissue Res"},{"key":"9197_CR63","doi-asserted-by":"publisher","first-page":"E751","DOI":"10.1152\/ajpendo.00745.2009","volume":"298","author":"N.B. Ruderman","year":"2010","unstructured":"Ruderman, N.B., Xu, X.J., Nelson, L., Cacicedo, J.M., Saha, A.K., Lan, F., and Ido, Y. (2010). AMPK and SIRT1: a long-standing partnership? Am J Physiol Endocrinol Metab 298, E751\u2013E760.","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"9197_CR64","doi-asserted-by":"publisher","first-page":"1825","DOI":"10.1161\/CIRCRESAHA.117.309633","volume":"120","author":"I.P. Salt","year":"2017","unstructured":"Salt, I.P., and Hardie, D.G. (2017). AMP-activated protein kinase. Circ Res 120, 1825\u20131841.","journal-title":"Circ Res"},{"key":"9197_CR65","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1517\/13543784.2012.696609","volume":"21","author":"I.P. Salt","year":"2012","unstructured":"Salt, I.P., and Palmer, T.M. (2012). Exploiting the anti-inflammatory effects of AMP-activated protein kinase activation. Expert Opin Investig Drugs 21, 1155\u20131167.","journal-title":"Expert Opin Investig Drugs"},{"key":"9197_CR66","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1016\/j.ejphar.2014.05.003","volume":"737","author":"H. Soraya","year":"2014","unstructured":"Soraya, H., Clanachan, A.S., Rameshrad, M., Maleki-Dizaji, N., Ghazi-Khansari, M., and Garjani, A. (2014). Chronic treatment with metformin suppresses toll-like receptor 4 signaling and attenuates left ventricular dysfunction following myocardial infarction. Eur J Pharmacol 737, 77\u201384.","journal-title":"Eur J Pharmacol"},{"key":"9197_CR67","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1016\/j.intimp.2012.10.014","volume":"14","author":"H. Soraya","year":"2012","unstructured":"Soraya, H., Farajnia, S., Khani, S., Rameshrad, M., Khorrami, A., Banani, A., Maleki-Dizaji, N., and Garjani, A. (2012b). Short-term treatment with metformin suppresses toll like receptors (TLRS) activity in isoproterenol-induced myocardial infarction in rat: are AMPK and TLRS connected? Int Immunopharmacol 14, 785\u2013791.","journal-title":"Int Immunopharmacol"},{"key":"9197_CR68","doi-asserted-by":"publisher","first-page":"1476","DOI":"10.1016\/S1734-1140(12)70945-3","volume":"64","author":"H. Soraya","year":"2012","unstructured":"Soraya, H., Khorrami, A., Garjani, A., Maleki-Dizaji, N., and Garjani, A. (2012a). Acute treatment with metformin improves cardiac function following isoproterenol induced myocardial infarction in rats. Pharmacol Rep 64, 1476\u20131484.","journal-title":"Pharmacol Rep"},{"key":"9197_CR69","doi-asserted-by":"publisher","first-page":"3","DOI":"10.15171\/bi.2015.02","volume":"5","author":"H. Soraya","year":"2015","unstructured":"Soraya, H., Rameshrad, M., Mokarizadeh, A., and Garjani, A. (2015). Metformin attenuates myocardial remodeling and neutrophil recruitment after myocardial infarction in rat. Bioimpacts 5, 3\u20138.","journal-title":"Bioimpacts"},{"key":"9197_CR70","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1161\/CIRCULATIONAHA.106.630194","volume":"114","author":"W. Sun","year":"2006","unstructured":"Sun, W., Lee, T.S., Zhu, M., Gu, C., Wang, Y., Zhu, Y., and Shyy, J.Y.J. (2006). Statins activate AMP-activated protein kinase in vitro and in vivo. Circulation 114, 2655\u20132662.","journal-title":"Circulation"},{"key":"9197_CR71","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1111\/nyas.12839","volume":"1348","author":"M.M. Sung","year":"2015","unstructured":"Sung, M.M., and Dyck, J.R.B. (2015). Therapeutic potential of resveratrol in heart failure. Ann NY Acad Sci 1348, 32\u201345.","journal-title":"Ann NY Acad Sci"},{"key":"9197_CR72","doi-asserted-by":"publisher","first-page":"9554","DOI":"10.1128\/MCB.25.21.9554-9575.2005","volume":"25","author":"K. Terai","year":"2005","unstructured":"Terai, K., Hiramoto, Y., Masaki, M., Sugiyama, S., Kuroda, T., Hori, M., Kawase, I., and Hirota, H. (2005). AMP-activated protein kinase protects cardiomyocytes against hypoxic injury through attenuation of endoplasmic reticulum stress. Mol Cell Biol 25, 9554\u20139575.","journal-title":"Mol Cell Biol"},{"key":"9197_CR73","doi-asserted-by":"publisher","first-page":"1401","DOI":"10.1007\/s00204-015-1477-x","volume":"89","author":"Y.K. Tham","year":"2015","unstructured":"Tham, Y.K., Bernardo, B.C., Ooi, J.Y.Y., Weeks, K.L., and McMullen, J.R. (2015). Pathophysiology of cardiac hypertrophy and heart failure: signaling pathways and novel therapeutic targets. Arch Toxicol 89, 1401\u20131438.","journal-title":"Arch Toxicol"},{"key":"9197_CR74","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/hc4001.097183","volume":"104","author":"R. Tian","year":"2001","unstructured":"Tian, R., Musi, N., D\u2019Agostino, J., Hirshman, M.F., and Goodyear, L.J. (2001). Increased adenosine monophosphate-activated protein kinase activity in rat hearts with pressure-overload hypertrophy. Circulation 104, 1664\u20131669.","journal-title":"Circulation"},{"key":"9197_CR75","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1161\/CIRCRESAHA.107.158220","volume":"102","author":"L. Timmers","year":"2008","unstructured":"Timmers, L., Sluijter, J.P.G., van Keulen, J.K., Hoefer, I.E., Nederhoff, M.G.J., Goumans, M.J., Doevendans, P.A., van Echteld, C.J.A., Joles, J.A., Quax, P.H., Piek, J.J., Pasterkamp, G., and de Kleijn, D.P.V. (2008). Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circul Res 102, 257\u2013264.","journal-title":"Circul Res"},{"key":"9197_CR76","doi-asserted-by":"publisher","first-page":"1021","DOI":"10.1161\/CIRCRESAHA.115.306565","volume":"118","author":"J.G. Travers","year":"2016","unstructured":"Travers, J.G., Kamal, F.A., Robbins, J., Yutzey, K.E., and Blaxall, B.C. (2016). Cardiac fibrosis. Circ Res 118, 1021\u20131040.","journal-title":"Circ Res"},{"key":"9197_CR77","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1016\/j.intimp.2016.10.002","volume":"40","author":"H. Vaez","year":"2016","unstructured":"Vaez, H., Najafi, M., Rameshrad, M., Toutounchi, N.S., Garjani, M., Barar, J., and Garjani, A. (2016). AMPK activation by metformin inhibits local innate immune responses in the isolated rat heart by suppression of TLR 4-related pathway. Int Immunopharmacol 40, 501\u2013507.","journal-title":"Int Immunopharmacol"},{"key":"9197_CR78","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.yjmcc.2016.04.009","volume":"97","author":"J. Voelkl","year":"2016","unstructured":"Voelkl, J., Alesutan, I., Primessnig, U., Feger, M., Mia, S., Jungmann, A., Castor, T., Viereck, R., St\u00f6ckigt, F., Borst, O., Gawaz, M., Schrickel, J.W., Metzler, B., Katus, H.A., M\u00fcller, O.J., Pieske, B., Heinzel, F.R., and Lang, F. (2016). AMP-activated protein kinase \u03b11-sensitive activation of AP-1 in cardiomyocytes. J Mol Cell Cardiol 97, 36\u201343.","journal-title":"J Mol Cell Cardiol"},{"key":"9197_CR79","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1111\/acel.12507","volume":"15","author":"B. Wang","year":"2016","unstructured":"Wang, B., Zeng, H., Wen, Z., Chen, C., and Wang, D.W. (2016a). CYP2J2 and its metabolites (epoxyeicosatrienoic acids) attenuate cardiac hypertrophy by activating AMPK\u03b12 and enhancing nuclear translocation of Akt1. Aging Cell 15, 940\u2013952.","journal-title":"Aging Cell"},{"key":"9197_CR80","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1097\/FJC.0000000000000290","volume":"66","author":"L. Wang","year":"2015","unstructured":"Wang, L., Gao, M., Chen, J., Yang, Z., Sun, J., Wang, Z., Huang, X., Yuan, T., Shen, X., and Xian, S. (2015). Resveratrol ameliorates pressure overload-induced cardiac dysfunction and attenuates autophagy in rats. J Cardiovasc Pharmacol 66, 376\u2013382.","journal-title":"J Cardiovasc Pharmacol"},{"key":"9197_CR81","volume-title":"Br J Pharmacol","author":"S. Wang","year":"2017","unstructured":"Wang, S., Binder, P., Fang, Q., Wang, Z., Xiao, W., Liu, W., and Wang, X. (2017). Endoplasmic reticulum stress in the heart: insights into mechanisms and drug targets. Br J Pharmacol in press doi: 10.1111\/bph.13888."},{"key":"9197_CR82","doi-asserted-by":"publisher","first-page":"555","DOI":"10.1042\/CS20110625","volume":"122","author":"S. Wang","year":"2012","unstructured":"Wang, S., Song, P., and Zou, M.H. (2012). AMP-activated protein kinase, stress responses and cardiovascular diseases. Clin Sci 122, 555\u2013573.","journal-title":"Clin Sci"},{"key":"9197_CR83","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1007\/s00395-016-0531-z","volume":"111","author":"X.X. Wang","year":"2016","unstructured":"Wang, X.X., Wang, X.L., Tong, M., Gan, L., Chen, H., Wu, S., Chen, J.X., Li, R.L., Wu, Y., Zhang, H., Zhu, Y., Li, Y., He, J., Wang, M., and Jiang, W. (2016b). SIRT6 protects cardiomyocytes against ischemia\/reperfusion injury by augmenting FoxO3\u03b1-dependent antioxidant defense mechanisms. Basic Res Cardiol 111, 13.","journal-title":"Basic Res Cardiol"},{"key":"9197_CR84","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1042\/CS20080066","volume":"116","author":"A.K.F. Wong","year":"2009","unstructured":"Wong, A.K.F., Howie, J., Petrie, J.R., and Lang, C.C. (2009). AMP-activated protein kinase pathway: a potential therapeutic target in cardiometabolic disease. Clin Sci 116, 607\u2013620.","journal-title":"Clin Sci"},{"key":"9197_CR85","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.1007\/s00109-015-1309-8","volume":"93","author":"D. Wu","year":"2015","unstructured":"Wu, D., Lei, H., Wang, J.Y., Zhang, C.L., Feng, H., Fu, F.Y., Li, L., and Wu, L.L. (2015). CTRP3 attenuates post-infarct cardiac fibrosis by targeting Smad3 activation and inhibiting myofibroblast differentiation. J Mol Med 93, 1311\u20131325.","journal-title":"J Mol Med"},{"key":"9197_CR86","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1093\/cvr\/cvq066","volume":"87","author":"H. Xiao","year":"2010","unstructured":"Xiao, H., Ma, X., Feng, W., Fu, Y., Lu, Z., Xu, M., Shen, Q., Zhu, Y., and Zhang, Y. (2010). Metformin attenuates cardiac fibrosis by inhibiting the TGF\u03b21-Smad3 signalling pathway. Cardiovasc Res 87, 504\u2013513.","journal-title":"Cardiovasc Res"},{"key":"9197_CR87","doi-asserted-by":"publisher","first-page":"28597","DOI":"10.1038\/srep28597","volume":"6","author":"H. Xiao","year":"2016","unstructured":"Xiao, H., Zhang, J., Xu, Z., Feng, Y., Zhang, M., Liu, J., Chen, R., Shen, J., Wu, J., Lu, Z., Fang, X., Li, J., and Zhang, Y. (2016). Metformin is a novel suppressor for transforming growth factor (TGF)-\u03b21. Sci Rep 6, 28597.","journal-title":"Sci Rep"},{"key":"9197_CR88","volume-title":"Planta Med","author":"Y. Xiao","year":"2017","unstructured":"Xiao, Y., Chang, W., Wu, Q.Q., Jiang, X.H., Duan, M.X., Jin, Y.G., and Tang, Q.Z. (2017). Aucubin protects against TGF\u03b21-induced cardiac fibroblasts activation by mediating the AMPK\u03b1\/mTOR signaling pathway. Planta Med in press doi: 10.1055\/s-0043-118663."},{"key":"9197_CR89","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1161\/HYPERTENSIONAHA.113.02619","volume":"63","author":"X. Xu","year":"2014","unstructured":"Xu, X., Lu, Z., Fassett, J., Zhang, P., Hu, X., Liu, X., Kwak, D., Li, J., Zhu, G., Tao, Y., Hou, M., Wang, H., Guo, H., Viollet, B., McFalls, E.O., Bache, R.J., and Chen, Y. (2014). Metformin protects against systolic overload-induced heart failure independent of AMP-activated protein kinase \u03b12novelty and significance. Hypertension 63, 723\u2013728.","journal-title":"Hypertension"},{"key":"9197_CR90","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1016\/j.bbrc.2008.09.057","volume":"376","author":"E. Zarrinpashneh","year":"2008","unstructured":"Zarrinpashneh, E., Beauloye, C., Ginion, A., Pouleur, A.C., Havaux, X., Hue, L., Viollet, B., Vanoverschelde, J.L., and Bertrand, L. (2008). AMPK\u03b12 counteracts the development of cardiac hypertrophy induced by isoproterenol. Biochem Biophys Res Commun 376, 677\u2013681.","journal-title":"Biochem Biophys Res Commun"},{"key":"9197_CR91","doi-asserted-by":"publisher","first-page":"a022129","DOI":"10.1101\/cshperspect.a022129","volume":"9","author":"Y.E. Zhang","year":"2017","unstructured":"Zhang, Y.E. (2017). Non-smad signaling pathways of the TGF-\u03b2 family. Cold Spring Harb Perspect Biol 9, a022129.","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"9197_CR92","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1016\/j.bbadis.2014.04.023","volume":"1852","author":"Q. Zheng","year":"2015","unstructured":"Zheng, Q., Zhao, K., Han, X., Huff, A.F., Cui, Q., Babcock, S.A., Yu, S., and Zhang, Y. (2015). Inhibition of AMPK accentuates prolonged caloric restriction-induced change in cardiac contractile function through disruption of compensatory autophagy. Biochim Biophys Acta 1852, 332\u2013342.","journal-title":"Biochim Biophys Acta"},{"key":"9197_CR93","doi-asserted-by":"publisher","first-page":"1167","DOI":"10.1172\/JCI13505","volume":"108","author":"G. Zhou","year":"2001","unstructured":"Zhou, G., Myers, R., Li, Y., Chen, Y., Shen, X., Fenyk-Melody, J., Wu, M., Ventre, J., Doebber, T., Fujii, N., Musi, N., Hirshman, M.F., Goodyear, L.J., and Moller, D.E. (2001). Role of AMP-activated protein kinase in mechanism of metformin action. J Clin Invest 108, 1167\u20131174.","journal-title":"J Clin Invest"},{"key":"9197_CR94","doi-asserted-by":"publisher","first-page":"800","DOI":"10.1007\/s10495-013-0843-5","volume":"18","author":"X.Z. Zhuo","year":"2013","unstructured":"Zhuo, X.Z., Wu, Y., Ni, Y.J., Liu, J.H., Gong, M., Wang, X.H., Wei, F., Wang, T.Z., Yuan, Z., Ma, A.Q., and Song, P. (2013). Isoproterenol instigates cardiomyocyte apoptosis and heart failure via AMPK inactivation-mediated endoplasmic reticulum stress. Apoptosis 18, 800\u2013810.","journal-title":"Apoptosis"},{"key":"9197_CR95","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1016\/j.bbadis.2014.10.016","volume":"1852","author":"B.N.M. Zordoky","year":"2015","unstructured":"Zordoky, B.N.M., Robertson, I.M., and Dyck, J.R.B. (2015). Preclinical and clinical evidence for the role of resveratrol in the treatment of cardiovascular diseases. Biochim Biophys Acta 1852, 1155\u20131177.","journal-title":"Biochim Biophys Acta"}],"container-title":["Science China Life Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11427-017-9197-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-017-9197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11427-017-9197-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,4,26]],"date-time":"2018-04-26T15:33:05Z","timestamp":1524756785000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11427-017-9197-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,11,21]]},"references-count":95,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["9197"],"URL":"https:\/\/doi.org\/10.1007\/s11427-017-9197-5","relation":{},"ISSN":["1674-7305","1869-1889"],"issn-type":[{"value":"1674-7305","type":"print"},{"value":"1869-1889","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,11,21]]}}}